IL49640A - Oral oestrogenic preparation containing at least one 17 -ester of oestradiol ans a pharmaceutically acceptable non-steroid lipoid,and certain new 17 -esters of oestradiol - Google Patents

Oral oestrogenic preparation containing at least one 17 -ester of oestradiol ans a pharmaceutically acceptable non-steroid lipoid,and certain new 17 -esters of oestradiol

Info

Publication number
IL49640A
IL49640A IL49640A IL4964076A IL49640A IL 49640 A IL49640 A IL 49640A IL 49640 A IL49640 A IL 49640A IL 4964076 A IL4964076 A IL 4964076A IL 49640 A IL49640 A IL 49640A
Authority
IL
Israel
Prior art keywords
oestradiol
oestrogenic
lipoid
ans
steroid
Prior art date
Application number
IL49640A
Other languages
English (en)
Other versions
IL49640A0 (en
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of IL49640A0 publication Critical patent/IL49640A0/xx
Publication of IL49640A publication Critical patent/IL49640A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
IL49640A 1975-05-30 1976-05-24 Oral oestrogenic preparation containing at least one 17 -ester of oestradiol ans a pharmaceutically acceptable non-steroid lipoid,and certain new 17 -esters of oestradiol IL49640A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7506407A NL7506407A (nl) 1975-05-30 1975-05-30 Werkwijze ter bereiding van een oraal werkzaam far- maceutisch preparaat.

Publications (2)

Publication Number Publication Date
IL49640A0 IL49640A0 (en) 1976-12-31
IL49640A true IL49640A (en) 1980-10-26

Family

ID=19823842

Family Applications (1)

Application Number Title Priority Date Filing Date
IL49640A IL49640A (en) 1975-05-30 1976-05-24 Oral oestrogenic preparation containing at least one 17 -ester of oestradiol ans a pharmaceutically acceptable non-steroid lipoid,and certain new 17 -esters of oestradiol

Country Status (16)

Country Link
US (1) US4071623A (hr)
JP (2) JPS51144736A (hr)
AU (1) AU505898B2 (hr)
BE (1) BE842329A (hr)
DE (2) DE2624025A1 (hr)
FR (1) FR2312256A1 (hr)
GB (2) GB1553731A (hr)
GR (1) GR58257B (hr)
HU (1) HU176742B (hr)
IE (1) IE42692B1 (hr)
IL (1) IL49640A (hr)
LU (1) LU75039A1 (hr)
NL (1) NL7506407A (hr)
NZ (1) NZ180980A (hr)
PH (1) PH13841A (hr)
ZA (1) ZA762920B (hr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7613248A (nl) * 1976-11-26 1978-05-30 Akzo Nv Werkwijze voor het bereiden van nieuwe steroid- esters.
DD148185A1 (de) * 1979-05-21 1981-05-13 Claus Claussen Verfahren zur herstellung einer oral applizierbaren arzneiform
US4315925A (en) * 1980-05-30 1982-02-16 University Of Kentucky Research Foundation Method of administering natural female sex hormones
US4816257A (en) * 1985-09-20 1989-03-28 Research & Education Institute, Harbor-Ucla Medical Center Inc. Method for producing an in vivo environment suitable for human embryo transfer
US4863911A (en) * 1986-08-04 1989-09-05 University Of Florida Method for treating male sexual dysfunction
DK0393539T3 (da) * 1989-04-18 1993-09-27 Scherer Gmbh R P Oral præparatform indeholdende østradiolvalerat
DE59004243D1 (de) 1990-06-14 1994-02-24 Henning Berlin Gmbh Flüssig befüllte Steckkapselpräparate.
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
DE19619045C1 (de) * 1996-05-02 1997-11-13 Jenapharm Gmbh Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
CA2415349A1 (en) * 2000-08-23 2002-02-28 Akzo Nobel N.V. Testosterone ester formulation for human use
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
US20050287203A1 (en) * 2002-05-08 2005-12-29 Nijs De H Formulation comprising testosteron undecanoate and castor oil
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
MXPA05010871A (es) * 2003-04-11 2005-11-25 Barr Lab Inc Metodos para administrar estrogenos y progestinas.
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
PT1530965E (pt) 2003-11-11 2006-05-31 Udo Mattern Sistema de administracao de libertacao controlada de hormonas sexuais para aplicacao nasal
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
CN101600417B (zh) 2006-10-04 2012-05-30 M&P专利股份公司 用于神经递质的经鼻施用的控制释放递送系统
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US20130040923A1 (en) 2011-05-13 2013-02-14 Trimel Pharmaceuticals Corporation Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
PT2782584T (pt) 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990414A (en) * 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
CH502325A (de) * 1966-12-09 1971-01-31 Ciba Geigy Ag Verfahren zur Herstellung von Aldehyden der Pregnanreihe und ihrer Derivate
US3484465A (en) * 1967-09-07 1969-12-16 Syntex Corp Bicyclo(2.2.2)octane - 1-carboxylate carbonate esters of estrogenic steroids
US3608075A (en) * 1969-07-28 1971-09-21 American Home Prod Compositions and methods of treating the menopausal syndrome
FR2248029B1 (hr) * 1973-10-19 1977-03-11 Roussel Uclaf
US3916002A (en) * 1973-12-17 1975-10-28 Taubert Hans Dieter Oligomeric steroid esters, process for their production, and therapeutic compositions containing the same
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
AU505898B2 (en) 1979-12-06
JPS6245845B2 (hr) 1987-09-29
GR58257B (en) 1977-09-15
JPS51144736A (en) 1976-12-13
AU1413576A (en) 1977-11-24
DE2624025C2 (hr) 1989-03-16
IE42692L (en) 1976-11-30
BE842329A (fr) 1976-11-29
LU75039A1 (hr) 1977-01-20
FR2312256B1 (hr) 1980-04-30
PH13841A (en) 1980-10-16
DE2624025A1 (de) 1976-12-09
GB1553731A (en) 1979-09-26
DE2661011C2 (de) 1986-12-11
GB1553732A (en) 1979-09-26
NZ180980A (en) 1978-06-20
US4071623A (en) 1978-01-31
FR2312256A1 (fr) 1976-12-24
NL7506407A (nl) 1976-12-02
JPS62281892A (ja) 1987-12-07
ZA762920B (en) 1977-04-27
HU176742B (en) 1981-05-28
IE42692B1 (en) 1980-09-24
IL49640A0 (en) 1976-12-31

Similar Documents

Publication Publication Date Title
IL49640A (en) Oral oestrogenic preparation containing at least one 17 -ester of oestradiol ans a pharmaceutically acceptable non-steroid lipoid,and certain new 17 -esters of oestradiol
JPS53121922A (en) Sanitary preparation for dentistry and oral cavety
JPS5555113A (en) Oral administration medical tablet and its manufacture
NZ222761A (en) Device for transdermal administration of ethinyl estradiol and levonorgestrel
ZA877420B (en) Transdermal administration of progesterone,estradiol esters,and mixtures thereof
EP0136011A3 (en) A method of hormonal treatment of peri-menopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
GB2039737B (en) Galenical forms for administration of medicaments by oral by oral route with programmed release and processes for preparing same
PT84416A (en) Process for the preparation of dosage forms having a regular and sustained release for oral administration containing polysaccharides of natural origin
GB1550568A (en) Steroid spirolactones and process for their preparation
AU516852B2 (en) Proportioning powdered medicament venturi inhalator
SG29994G (en) Steroidal drug-containing preparation for external use
FI884378A0 (fi) Farmaceutiskt preparat och foerfarande foer framstaellning av detsamma.
EP0001295A3 (en) Somatostatin-like cyclopeptides, a process for their preparation, pharmaceutical compositions containing them, and their therapeutical application
ZA764868B (en) Novel pharmaceutical preparation adapted for oral administration
PH20276A (en) New prostacyclin derivatives and pharmaceutical preparation thereof
IE42950L (en) X-ray contrast preparations
JPS51133435A (en) New oral drug composition for protection of mouth cavity and tooth
JPS5555200A (en) Steroid compound and medicine composition
NZ236110A (en) Stigmastanyl and cholestanyl steroid derivatives; pharmaceutical compositions and preparatory processes
NZ184731A (en) Analogues of luteninising hormone releasing factor; pharmaceutical and veterinary compositions
DE3263932D1 (en) Guar gum preparation forms for oral administration
DE2862121D1 (en) Toilet and dental preparations and their use for oral and dental hygiene
PH15545A (en) A contraceptive composition consisting of an androstene and a procestogen and method of use thereof
JPS5219649A (en) Novel triaminoo androstane derivatives and preparation thereof
IL54169A (en) Steroid spirooxazolidines,their preparation and pharmaceutical compositions containing them